|Articles|November 18, 2015
Michael J. Mauro Discusses the Diagnosis of CML
Author(s)Michael J. Mauro
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life
3
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
4
How a Teen Cancer Survivor and Her Best Friend Created an App to Help Patients Between Appointments
5